Related Experiment Videos

Immunity to hepatitis B among health care workers performing exposure prone procedures

C J Poole¹, S Miller, G Fillingham

¹Occupational Health Service, Dudley Health Authority, Central Clinic.

BMJ (Clinical Research Ed.)

|July 9, 1994

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes.

Annals of oncology : official journal of the European Society for Medical Oncology·2015

Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients.

Annals of oncology : official journal of the European Society for Medical Oncology·2014

Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials.

British journal of cancer·2012

A randomized phase II study evaluating the combination of carboplatin-based chemotherapy with pertuzumab versus carboplatin-based therapy alone in patients with relapsed, platinum-sensitive ovarian cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2012

NEAT: National Epirubicin Adjuvant Trial--toxicity, delivered dose intensity and quality of life.

British journal of cancer·2008

tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmonary, cardiac and hepatic function evaluation.

British journal of cancer·2008

See all related articles